Nefrite intersticial aguda

Raghavan R, Eknoyan G. Acute interstitial nephritis - a reappraisal and update. Clin Nephrol. 2014 Sep;82(3):149-62.Texto completo  Resumo

Praga M, Sevillano A, Auñón P, et al. Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury. Nephrol Dial Transplant. 2015 Sep;30(9):1472-9.Texto completo  Resumo

Moledina DG, Eadon MT, Calderon F, et al. Development and external validation of a diagnostic model for biopsy-proven acute interstitial nephritis using electronic health record data. Nephrol Dial Transplant. 2022 Oct 19;37(11):2214-22.Texto completo  Resumo

Moledina DG, Perazella MA. Drug-induced acute interstitial nephritis. Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2046-9.Texto completo  Resumo

1. Raghavan R, Eknoyan G. Acute interstitial nephritis - a reappraisal and update. Clin Nephrol. 2014 Sep;82(3):149-62.Texto completo  Resumo

2. Chu R, Li C, Wang S, et al. Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease. Clin J Am Soc Nephrol. 2014 Jul;9(7):1175-82.Texto completo  Resumo

3. Muriithi AK, Leung N, Valeri AM, et al. Biopsy-proven acute interstitial nephritis, 1993-2011: a case series. Am J Kidney Dis. 2014 Oct;64(4):558-66. Resumo

4. Praga M, Sevillano A, Auñón P, et al. Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury. Nephrol Dial Transplant. 2015 Sep;30(9):1472-9.Texto completo  Resumo

5. Antoniou T, Macdonald EM, Hollands S, et al. Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study. CMAJ Open. 2015 Apr-Jun;3(2):E166-71.Texto completo  Resumo

6. Wilson GJ, Kark AL, Francis LP, et al. The increasing rates of acute interstitial nephritis in Australia: a single centre case series. BMC Nephrol. 2017 Oct 31;18(1):329.Texto completo  Resumo

7. United States Renal Data System. 2019 USRDS annual data report: Epidemiology of kidney disease in the United States. 2019 [internet publication].Texto completo

8. Nast CC. Medication-induced interstitial nephritis in the 21st century. Adv Chronic Kidney Dis. 2017 Mar;24(2):72-9. Resumo

9. Muriithi AK, Leung N, Valeri AM, et al. Clinical characteristics, causes and outcomes of acute interstitial nephritis in the elderly. Kidney Int. 2015 Feb;87(2):458-64.Texto completo  Resumo

10. Raghavan R, Shawar S. Mechanisms of drug-induced interstitial nephritis. Adv Chronic Kidney Dis. 2017 Mar;24(2):64-71. Resumo

11. Perazella MA, Markowitz GS. Drug-induced acute interstitial nephritis. Nat Rev Nephrol. 2010 Aug;6(8):461-70. Resumo

12. Rosner MH, Perazella MA. Acute kidney injury in the patient with cancer. Kidney Res Clin Pract. 2019 Sep 30;38(3):295-308.Texto completo  Resumo

13. Cassol C, Satoskar A, Lozanski G, et al. Anti-PD-1 immunotherapy may induce interstitial nephritis with increased tubular epithelial expression of PD-L1. Kidney Int Rep. 2019 Aug;4(8):1152-60.Texto completo  Resumo

14. Joyce E, Glasner P, Ranganathan S, et al. Tubulointerstitial nephritis: diagnosis, treatment, and monitoring. Pediatr Nephrol. 2017 Apr;32(4):577-87.Texto completo  Resumo

15. Praga M, González E. Acute interstitial nephritis. Kidney Int. 2010 Jun;77(11):956-61.Texto completo  Resumo

16. Zand L, Monaghan M, Griffin BR, et al. The role of type I hypersensitivity reaction and IgE-mediated mast cell activation in acute interstitial nephritis. Clin Nephrol. 2015 Sep;84(3):138-44. Resumo

17. Spanou Z, Keller M, Britschgi M, et al. Involvement of drug-specific T cells in acute drug-induced interstitial nephritis. J Am Soc Nephrol. 2006 Oct;17(10):2919-27.Texto completo  Resumo

18. Goicoechea M, Rivera F, López-Gómez JM, et al. Increased prevalence of acute tubulointerstitial nephritis. Nephrol Dial Transplant. 2013 Jan;28(1):112-5.Texto completo  Resumo

19. Moledina DG, Parikh CR. Differentiating acute interstitial nephritis from acute tubular injury: a challenge for clinicians. Nephron. 2019;143(3):211-6.Texto completo  Resumo

20. Fogazzi GB, Ferrari B, Garigali G, et al. Urinary sediment findings in acute interstitial nephritis. Am J Kidney Dis. 2012 Aug;60(2):330-2.Texto completo  Resumo

21. Muriithi AK, Nasr SH, Leung N. Utility of urine eosinophils in the diagnosis of acute interstitial nephritis. Clin J Am Soc Nephrol. 2013 Nov;8(11):1857-62. [Erratum in: Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1079.]Texto completo  Resumo

22. Perazella MA, Bomback AS. Urinary eosinophils in AIN: farewell to an old biomarker? Clin J Am Soc Nephrol. 2013 Nov;8(11):1841-3.Texto completo  Resumo

23. Moledina DG, Eadon MT, Calderon F, et al. Development and external validation of a diagnostic model for biopsy-proven acute interstitial nephritis using electronic health record data. Nephrol Dial Transplant. 2022 Oct 19;37(11):2214-22.Texto completo  Resumo

24. Moledina DG, Luciano RL, Kukova L, et al. Kidney biopsy-related complications in hospitalized patients with acute kidney disease. Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1633-40.Texto completo  Resumo

25. Korbet SM, Gashti CN, Evans JK, et al. Risk of percutaneous renal biopsy of native kidneys in the evaluation of acute kidney injury. Clin Kidney J. 2018 Oct;11(5):610-5.Texto completo  Resumo

26. Graham F, Lord M, Froment D, et al. The use of gallium-67 scintigraphy in the diagnosis of acute interstitial nephritis. Clin Kidney J. 2016 Feb;9(1):76-81.Texto completo  Resumo

27. Moledina DG, Wilson FP, Pober JS, et al. Urine TNF-alpha and IL-9 for clinical diagnosis of acute interstitial nephritis. JCI Insight. 2019 May 16;4(10):127456.Texto completo  Resumo

28. Quinto LR, Sukkar L, Gallagher M. Effectiveness of corticosteroid compared with non-corticosteroid therapy for the treatment of drug-induced acute interstitial nephritis: a systematic review. Intern Med J. 2019 May;49(5):562-9. Resumo

29. Valluri A, Hetherington L, Mcquarrie E, et al. Acute tubulointerstitial nephritis in Scotland. QJM. 2015 Jul;108(7):527-32. Resumo

30. Clarkson MR, Giblin L, O'Connell FP, et al. Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant. 2004 Nov;19(11):2778-83.Texto completo  Resumo

31. Raza MN, Hadid M, Keen CE, et al. Acute tubulointerstitial nephritis, treatment with steroid and impact on renal outcomes. Nephrology (Carlton). 2012 Nov;17(8):748-53. Resumo

32. González E, Gutiérrez E, Galeano C, et al; Grupo Madrileño De Nefritis Intersticiales.. Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int. 2008 Apr;73(8):940-6.Texto completo  Resumo

33. Moledina DG, Perazella MA. Drug-induced acute interstitial nephritis. Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2046-9.Texto completo  Resumo

34. Preddie DC, Markowitz GS, Radhakrishnan J, et al. Mycophenolate mofetil for the treatment of interstitial nephritis. Clin J Am Soc Nephrol. 2006 Jul;1(4):718-22.Texto completo  Resumo

35. Lin JS, Mamlouk O, Selamet U, et al. Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis. Oncoimmunology. 2021 Feb 2;10(1):1877415.Texto completo  Resumo

36. Caravaca-Fontán F, Shabaka A, Sánchez-Álamo B, et al. Recurrent acute interstitial nephritis: what lies beneath. Clin Kidney J. 2021 Jan;14(1):197-204.Texto completo  Resumo

37. Chen D, Luo C, Tang Z, et al. Delayed renal function recovery from drug-induced acute interstitial nephritis. Am J Med Sci. 2012 Jan;343(1):36-9. Resumo

38. Baker ML, Yamamoto Y, Perazella MA, et al. Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy. J Immunother Cancer. 2022 Mar;10(3):e004421.Texto completo  Resumo